My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Health Catalyst, Inc - Common stock (NQ:HCAT)

2.850 -0.100 (-3.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Health Catalyst, Inc - Common stock

< Previous 1 2 3 4 5 6 7 Next >
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Veeva Systems Stock Scores Rising Relative Strength Rating
The Relative Strength (RS) Rating for Veeva Systems stock climbed into a higher percentile Thursday, as it got a lift from 67 to 72. 
Via Investor's Business Daily
Health Catalyst Reports Second Quarter 2023 Results
From Health Catalyst, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
 
Via Benzinga
7 Analysts Have This to Say About Health Catalyst
 
Via Benzinga
Analyst Expectations for Health Catalyst's Future
 
Via Benzinga
Expert Ratings for Health Catalyst
 
Via Benzinga
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst to Announce Second Quarter 2023 Operating Results and Host Conference Call on Tuesday, August 8, 2023
From Health Catalyst, Inc.
Via GlobeNewswire
Growing Number of Industries Realize the Urgency for Ransomware Protection
EQNX::TICKER_START (NASDAQ:HCTI),(NASDAQ:HCAT),(NYSE:EVH),(NASDAQ:DH),(NASDAQ:NXGN) EQNX::TICKER_END 
Via FinancialNewsMedia
What 6 Analyst Ratings Have To Say About Health Catalyst
Health Catalyst (NASDAQ:HCAT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Health Catalyst's Q1 Earnings: Analysts Diverge on Outlook as Company Faces Demand Headwinds and Revenue Outperformance
Health Catalyst Inc (NASDAQ: HCAT) reported Q1 sales of $73.87 million, up 22% Y/Y, beating the consensus of $71.24 million< 
Via Benzinga
Nasdaq, S&P 500 Higher As Bond Yields Retreat
Investor sentiment is boosted today by a better-than-expected consumer price index (CPI) reading for April. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
 
Via Benzinga
Health Catalyst Reports First Quarter 2023 Results
From Health Catalyst, Inc.
Via GlobeNewswire
Why Shares of Health Catalyst Popped 23.34% on Wednesday
The company continued its upward trend in revenue growth. 
Via The Motley Fool
Health Catalyst to Announce First Quarter 2023 Operating Results and Host Conference Call on Tuesday, May 9, 2023
From Health Catalyst, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
 
Via Benzinga
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
Why Health Catalyst Stock Rallied Wednesday Morning
The data analytics specialist delivered results that weren't as bad as investors had feared. 
Via The Motley Fool
Health Catalyst Reports Fourth Quarter and Year End 2022 Results
From Health Catalyst, Inc.
Via GlobeNewswire
Health Catalyst to Announce Fourth Quarter and Full Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
From Health Catalyst, Inc.
Via GlobeNewswire
What Does Amazon's Acquisition of 1LifeMedical Mean To Investors?
After the announcement in July, the Amazon acquisition of One Medical is complete. What does this deal mean for healthcare or tech investors? 
Via MarketBeat
Topics Initial Public Offering Regulatory Compliance
3 Top Tech Stocks That Could Help Make You Rich by Retirement
These companies are raining down revenue from cloud computing. 
Via The Motley Fool
Health Catalyst to Participate in Upcoming Investor Conference
From Health Catalyst, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Phillips 66 To Rally 25%? Here Are 5 Other Price Target Changes For Thursday
 
Via Benzinga
Analyst Ratings for Health Catalyst
Over the past 3 months, 6 analysts have published their opinion on Health Catalyst (NASDAQ:HCAT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.